What is the recommended dose of promethazine (Phenergan) for an adult patient with nausea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Promethazine Dosing for Nausea in Adults

For nausea and vomiting in adults, administer promethazine 12.5-25 mg orally or intravenously every 4-6 hours as needed, with the FDA-approved standard dose being 25 mg. 1

Standard Dosing Recommendations

The FDA label establishes the following dosing parameters for nausea and vomiting 1:

  • Initial dose: 25 mg (oral, IV, or rectal)
  • Repeat dosing: 12.5-25 mg every 4-6 hours as needed
  • Prophylactic dosing: 25 mg repeated at 4-6 hour intervals for prevention during surgery and postoperative period

Evidence-Based Lower Dose Options

Consider starting with 6.25-12.5 mg IV for comparable efficacy with reduced sedation, particularly when sedation is undesirable or when used with opioids 2, 3:

  • 6.25 mg IV provides 74% relief at 1 hour, equivalent to ondansetron 4 mg, with significantly fewer adverse effects 2
  • 12.5 mg IV achieves 68% relief at 1 hour with minimal difference in efficacy compared to 6.25 mg 2
  • Lower doses (6.25 mg) result in less sedation at discharge compared to 12.5 mg, while maintaining equivalent antiemetic efficacy 3

Clinical Context and Route Selection

Oral/Rectal Administration

  • Standard dose: 25 mg every 4-6 hours 1
  • Reduced dose: 12.5 mg may be appropriate when sedation is problematic 1
  • Oral bioavailability is approximately 25%, though FDA dosing does not differentiate by route 2

Intravenous Administration

  • Infuse slowly to minimize hypotension risk 4
  • Clinical effects evident within 5 minutes, duration 4-6 hours 4
  • 12.5-25 mg IV is the recommended range for procedural sedation as adjunct to narcotics 4

Special Clinical Situations

Opioid-Induced Nausea

The NCCN guidelines specifically recommend promethazine 12.5-25 mg PO every 6 hours for patients with prior history of opioid-induced nausea 5:

  • Use prophylactically in patients with known opioid-induced nausea 5
  • Consider as breakthrough treatment for chemotherapy-induced nausea at 12.5-25 mg PO or IV every 4 hours 4

Cyclic Vomiting Syndrome

  • 12.5-25 mg orally or rectally every 4-6 hours as abortive therapy during acute episodes 4

Elderly Patients

Start with 6.25 mg IV in patients ≥65 years 6:

  • 6.25 mg is as effective as higher doses with significantly fewer adverse drug reactions (P = 0.048) 6
  • No difference in time to relief between 6.25 mg and 12.5 mg groups 6

Critical Safety Considerations

Sedation Profile

  • CNS depression and sedation occur frequently, which may be advantageous when sedation is desired but problematic otherwise 4
  • Promethazine is more sedating than prochlorperazine, metoclopramide, or ondansetron 7
  • Use cautiously when combined with opioids or other CNS depressants 4

Other Adverse Effects

  • Hypotension with rapid IV administration 4
  • Respiratory depression potential 4
  • Extrapyramidal symptoms can develop, similar to other dopamine antagonists 4
  • Dizziness, blurred vision, dry mouth 4

Contraindications

  • Absolutely contraindicated in children under 2 years due to fatal respiratory depression risk 4, 1

Practical Algorithm for Dose Selection

  1. Start with 12.5 mg IV/PO for most adult patients with nausea 1
  2. Use 6.25 mg IV if patient is elderly (≥65 years), receiving concurrent opioids, or when sedation is undesirable 2, 6
  3. Escalate to 25 mg if inadequate response after 4-6 hours 1
  4. Maximum single dose: 25 mg 1
  5. Repeat every 4-6 hours as needed 1

When Promethazine May Be Preferred

Promethazine is particularly useful when 4, 7:

  • Sedation is beneficial (nighttime dosing, anxious patients)
  • Other antiemetics have failed
  • Cost is a consideration
  • Opioid-induced pruritus is also present (dual benefit as antihistamine)

References

Research

A comparison of two differing doses of promethazine for the treatment of postoperative nausea and vomiting.

Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses, 2015

Guideline

Promethazine Mechanism and Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.